ϩ transport involve transcriptional downregulation of apical Na ϩ /H ϩ exchanger isoform 3 (NHE3). The aim of this study was to determine whether ouabain could acutely regulate NHE3 via a posttranscriptional mechanism in LLC-PK1 cells. We observed that the basolateral, but not apical, application of ouabain for 1 h significantly reduced transepithelial Na ϩ transport. This effect was not due to changes in the integrity of tight junctions or increases in the intracellular Na ϩ concentration. Ouabain regulated the trafficking of NHE3 and subsequently inhibited its activity, a process independent of intracellular Na ϩ concentration. Ouabain-induced NHE3 trafficking was abolished by either cholesterol depletion or Src inhibition. Moreover, ouabain increased the intracellular Ca 2ϩ concentration. Pretreatment of cells with the intracellular Ca 2ϩ chelator BAPTA-AM blocked ouabain-induced trafficking of NHE3. Also, blockade of Na ϩ -K ϩ -ATPase endocytosis by a phosphatidylinositol 3-kinase inhibitor was equally effective in attenuating ouabain-induced NHE3 trafficking. These data indicate that ouabain acutely stimulates NHE3 trafficking by activating the basolateral Na ϩ -K ϩ -ATPase signaling complex. Taken together with our previous observations, we propose that ouabain can simultaneously regulate basolateral Na ϩ -K ϩ -ATPase and apical NHE3, leading to inhibition of transepithelial Na ϩ transport. This mechanism may be relevant to proximal tubular Na ϩ handling during conditions associated with increases in circulating endogenous cardiotonic steroids.
kidney; sodium; sodium/hydrogen exchanger isoform 3; trafficking; c-Src; phosphatidylinositol 3-kinase SODIUM/HYDROGEN EXCHANGERS (NHEs) are present in all mammalian cells. They are involved in regulating intracellular pH, cellular volume, and cell growth. In the renal proximal tubule, NHE3 and Na ϩ -K ϩ -ATPase are critical in transepithelial Na ϩ reabsorption. We have previously reported that in LLC-PK1 cells (a widely accepted pig renal proximal tubule cell line), exposure to low concentrations of ouabain (Յ100 nM) for 12-24 h not only causes significant depletion of basolateral Na ϩ -K ϩ -ATPase but also induces downregulation of NHE3 expression and activity. These regulations are dependent on the ouabain-activated signaling function of Na ϩ -K ϩ -ATPase, and they cause substantial inhibition of transepithelial 22 Na ϩ transport without affecting the intracellular Na ϩ concentration ([Na ϩ ] i ) (33, 43) .
Endogenous cardiotonic steroids, including ouabain and marinobufagenin, are now accepted as a new class of steroid hormones that are involved in blood pressure regulation and renal Na ϩ handling (18, 19, 23, 26, 46) . Elevated endogenous ouabain levels have been found in a number of clinical conditions that are associated with plasma volume expansion such as chronic renal failure, hypertension, and congestive heart failure. The cardiotonic steroid binding site of Na ϩ -K ϩ -ATPase is believed to be the same molecular target of the hypertensive effects of these compounds, and this binding site appears to play an important role in blood pressure regulation (18) . Na ϩ reabsorption in the proximal tubule involves the coupling of apical Na ϩ entry via NHE3 and other transporters, whereas basolateral Na ϩ extrusion occurs primarily through Na ϩ -K ϩ -ATPase. Our previous observations have suggested that the effects of endogenous cardiotonic steroids on NHE3 may represent an adaptive response to volume expansion, a concept that resonates with early theories proposing the existence of one or more endogenous natriuretic compounds, as introduced by Dahl et al. (13) , Blaustein (8) , and de Wardener and Clarkson EM (14) . It seems logical to propose that synchronous regulation of Na ϩ -K ϩ -ATPase and NHE3 may present a functional loop that regulates coordinated transepithelial Na ϩ transport in this nephron segment. NHE3 activity is controlled by phosphorylation, trafficking, and transcriptional regulation. Regulated NHE3 trafficking has been demonstrated in many cases that involve clathrin-and/or lipid raft-dependent pathways (10, 31) . Although the specific mechanisms through which cardiotonic steroids affect NHE3-mediated renal Na ϩ handling are still being elucidated, evidence supports the notion that endogenous cardiotonic steroids might cause a physiologically meaningful regulation of transepithelial Na ϩ transport in the renal proximal tubule. NHE3 has been shown to be redistributed in hypertension, accompanying reversible downregulation of Na ϩ -K ϩ -ATPase activity in the renal cortex (56) . In opossum kidney cells, overexpression of the Na ϩ -K ϩ -ATPase ␣ 1 -subunit upregulated apical NHE3 activity and abundance, resulting in the stimulation of apical Na ϩ influx (20) . Parathyroid hormone and dopamine have been shown to stimulate endocytosis of Na ϩ -K ϩ -ATPase and NHE3 (9, 11, 25, 27) . Salt loading in vivo not only significantly depressed NHE3 expression but also induced Na ϩ -K ϩ -ATPase endocytosis in a marinobufagenin-dependent manner (3, 44) .
We have recently reported the mechanism through which ouabain-induced transcriptional downregulation of NHE3 oc-curs. This results in decreased transepithelial Na ϩ transport. Since we have shown that the activation of the basolateral Na ϩ -K ϩ -ATPase/Src receptor complex by ouabain stimulated endocytosis of Na ϩ -K ϩ -ATPase, we reasoned that this might also regulate NHE3 trafficking so that apical NHE3 activity can be coupled to the basolateral Na ϩ -K ϩ -ATPase activity to keep intracellular Na ϩ homeostasis. To test this hypothesis, the following experiments were conducted.
MATERIALS AND METHODS
Materials and cell culture. All chemicals, except otherwise mentioned, were obtained from Sigma (St. Louis, MO). Wortmannin, protein phosphatase 2 (PP2), and 1,2 bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetra-acetic acid-acetoxymethyl ester (BAPTA-AM) were obtained from Calbiochem (San Diego, CA). 22 Na ϩ was obtained from DuPont NEN Life Science (Boston, MA).
A rabbit polyclonal antibody against a mixture of peptides from porcine NHE3 was prepared and affinity purified (43) . Horseradish peroxidase-conjugated goat anti-rabbit IgG and antibodies against early endosome antigen-1 (EEA1), Rab5, and Rab7 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Polyclonal antibodies against occludin and claudin-1 were obtained from Zymed Laboratories (San Francisco, CA). A monoclonal antibody against the Na ϩ -K ϩ -ATPase ␣1-subunit (clone ␣6F) was obtained from the Hybridoma Bank of the University of Iowa (Iowa City, IA).
The LLC-PK1 cell line was obtained from the American Type Culture Collection (Manassas, VA) and cultured in DMEM containing 10% FBS, penicillin (100 U/ml), and streptomycin (100 g/ml) in a 5% CO2-humidified incubator. All cells were serum starved for 12 h before experiments. 22 Na ϩ transport. The intracellular pH recovery rate and 22 Na ϩ uptake were determined as previously described (43) . Calibration of intracellular pH was performed using high-K ϩ -nigericin (10 M) standards (41) . During measurements of intracellular pH and 22 Na ϩ uptake, 50 M amiloride was used to inhibit amiloride-sensitive NHE1 activity. To measure active transepithelial 22 Na ϩ flux, a transepithelial 22 Na ϩ transport assay was performed in LLC-PK1 monolayers (grown on Costar Transwell culture filter inserts, filter pore size: 0.4 m, Costar, Cambridge, MA). LLC-PK1 monolayers were first treated with or without ouabain (100 nM) applied in the basolateral or apical compartment, and active transepithelial 22 Na ϩ flux (apical to basolateral) was determined by counting radioactivity in the basolateral aspect at 1 h after 22 Na ϩ addition. Western blot analysis. Whole cell lysates were prepared using ice-cold RIPA buffer [containing 1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, 50 mM Tris ⅐ HCl (pH 7.4), 1 mM EDTA, 1 mM PMSF, 1 mM sodium orthovanadate, 1 mM NaF, 10 g/ml aprotinin, and 10 g/ml leupeptin]. Cell lysates were then centrifuged (4°C, 16,000 g, 10 min), and equal amounts of total protein from the supernatants were used for Western blot analysis. The membrane fraction was isolated as previously described (15) using nondetergent membrane buffer (same as RIPA buffer but without Nonidet P-40 and sodium deoxycholate). Cells were collected, homogenized, and microfuged (4°C, 16,000 g, 10 min) to remove insoluble cell debris and unbroken cells. Supernatants were further centrifuged (109,000 g at the maximum radius for 30 min at 4°C), and pellets were resuspended in 1ϫ Laemmli sample buffer. For the Western blot analysis, equal amounts of total protein were resolved by 10% SDS-PAGE and immunoblotted with antibodies against NHE3, the Na ϩ -K ϩ -ATPase ␣1-subunit, occludin, or claudin-1. The same membrane was stripped and immunoblotted with anti-tubulin antibody to serve as an internal loading control. Signal detection was performed with an enhanced chemiluminescence super signal kit (Pierce, Rockford, IL). Multiple exposures were analyzed to assure that the signals were within the linear range of the film. The signal density was determined using Molecular Analyst software (BioRad, Hercules, CA).
Measurements of intracellular Na
Labeling of cell surface proteins by biotinylation. Cell surface protein biotinylation was performed as previously described (22, 33) . LLC-PK1 cells were grown to form monolayers (6 -7 days) on 24-mm polycarbonate Transwell culture filter inserts (filter pore size: 0.4 m, Costar). The culture medium was replaced daily until 12 h before experiments, at which point the monolayer was serum starved. After surface biotinylation with EZ-Link sulfo-NHS-ss-Biotin (Pierce) and immobilization with ImmunoPure immobilized streptavidin-agarose beads (Pierce), biotinylated proteins were eluted by an incubation in a 55°C water bath for 30 min with an equal volume of 2ϫ Laemmli sample buffer, resolved by 10% SDS-PAGE, and then immunoblotted.
Isolation of early and late endosomes. Early and late endosomes were fractionated on a flotation gradient using the technique of Gorvel et al. (21) . Early and late endosome fractions were identified with antibodies against EEA1 and Rab5 (early endosome marker proteins) as well as Rab7 (late endosome marker protein). The method has been verified as we have previously described (33) . For each sample or treatment, LLC-PK1 cells were grown on three 150-mm dishes and subjected to endosomal isolation.
Cholesterol depletion and repletion. Methyl-␤-cyclodextrin (M␤-CD; Sigma) was dissolved in DMEM and used directly as previously described (50) . Cholesterol depletion was carried out by incubating the cells in the presence of 10 mM M␤-CD for 30 min at 37°C. Cells were washed twice with serum-free medium before experiments. Cholesterol repletion was carried out by incubating cholesterol-depleted cells with DMEM containing 4% (vol/vol) cholesterol-M␤-CD stock solution for 1 h at 37°C. Cholesterol-M␤-CD stock solution was prepared by mixing 200 l of cholesterol (20 mg/ml in ethanol) with 10 ml of 10% M␤-CD solution by vortexing at 40°C.
Immunofluorescence microscopy. Immunofluorescence and confocal microscopy were performed as previously described (33) . LLC-PK1 monolayers grown on Transwell filters were fixed in chilled (Ϫ20°C) methanol (100%), permeabilized for 15 min with permeabilization buffer (0.3% Triton X-100 and 0.1% BSA in PBS with 0.1 mM CaCl2 and 1 mM MgCl2), and blocked for 30 min with blocking buffer [containing 150 mM NaCl and 20 mM sodium phosphate (pH7.4) with 0.3% Triton X-100 and 16% (vol/vol) normal goat or horse serum]. Cells were incubated with primary antibodies (antioccludin or anti-claudin-1, 1:50 in blocking buffer) overnight at 4°C and washed three times with permeabilization buffer. Cells were then incubated with Alexa fluor 488-conjugated secondary antibody (1:100 in blocking buffer, Molecular Probes) for 1 h at room temperature, washed three times with permeabilization buffer, mounted in Prolong Antifade mounting medium (Molecular Probes), and dried in the dark overnight at room temperature. Confocal images were captured by a Leica TCS SP2 spectral confocal scanner and a Leica DMIRE2 microscope (Leica, Mannheim, Germany) equipped with a ϫ63 oilimmersion objective. Visualization and analysis were performed using Leica confocal microscope system software.
Statistical analysis. Data were tested for normality (all data passed) and then subjected to parametric analysis. When more than two groups were compared, one-way ANOVA was performed prior to comparison of individual groups with an unpaired t-test. Bonferroni's correction for multiple comparisons was employed as appropriate. Statistical significance was reported at the P Ͻ 0.05 and P Ͻ 0.01 levels. SPSS software was used for all analysis (SPSS, Chicago, IL).
RESULTS

Ouabain induces inhibition of NHE3 activity in LLC-PK1 cells.
We have shown that ouabain stimulates endocytosis of basolateral Na ϩ -K ϩ -ATPase in LLC-PK1 cells (33) . Over 12-24 h, ouabain reduced NHE3 mRNA and protein expression (43), leading to significantly reduced transepithelial Na ϩ transport in LLC-PK1 monolayers without altering [Na
Since 100 nM ouabain failed to increase intracellular Na ϩ , a balance of Na ϩ influx and efflux was expected. We assessed the acute effect of low concentrations of ouabain on NHE3 activity by measuring Na ϩ -dependent intracellular pH recovery and H ϩ -driven 22 Na ϩ uptake. For these measurements, LLC-PK1 cells were grown to confluence on glass coverslips or 12-well plates, serum starved for 12 h, and then treated with or without ouabain (100 nM) for different intervals. These assays were performed in the presence of 50 M amiloride to inhibit NHE1 activity. To determine H ϩ -driven Na ϩ uptake, cells were first acid loaded in Na ϩ -free buffer with 20 mM NH 4 Cl and then assayed for 22 Na ϩ uptake. Ouabain (100 nM) treatment significantly decreased H ϩ -driven 22 Na ϩ uptake in a time-dependent manner (Fig. 1A) . To determine if ouabaininduced decreases in 22 Na ϩ uptake were due to the inhibition of NHE3 activity, the Na ϩ -stimulated pH recovery rate after Na ϩ reintroduction was also determined. After ouabain treatment (100 nM, 1 h), the Na ϩ -stimulated pH recovery rate was also decreased by ϳ30% (0.22 Ϯ 0.04 pH units/min, n ϭ 8) compared with control cells (0.32 Ϯ 0.05 pH units/min, n ϭ 8, P Ͻ 0.01; Fig. 1B) . To evaluate the acute ouabain effect on transepithelial Na ϩ transport, LLC-PK1 cells were grown on Transwell filters to form monolayers. Ouabain (100 nM, 1 h) was applied to the basolateral or apical aspect, and transepi- Fig. 1 . Ouabain (Oua) inhibits Na ϩ /H ϩ exchanger isoform 3 (NHE3) activity and transepithelial 22 Na ϩ transport. LLC-PK1 cells were treated with or without 100 nM ouabain for the indicated times. H ϩ -driven 22 Na ϩ uptake, Na ϩ -dependent intracellular pH recovery, transepithelial 22 Na ϩ transport, and intracellular Na ϩ concentration ([Na ϩ ]i) were measured as described in MA-TERIALS AND METHODS. A: H ϩ -driven 22 Na ϩ uptake after ouabain (100 nM) treatment (n ϭ 6). B: Na ϩ -dependent intracellular pH recovery after ouabain (100 nM, 1 h) treatment (n ϭ 8). C: effects of ouabain (100 nM, 1 h) treatment on transepithelial 22 Na ϩ transport (n ϭ 6). Ouabain was applied in the basolateral (Baso) or apical aspect of LLC-PK1 monolayers grown on Transwell filter supports. D: effects of ouabain (100 nM) treatment on [Na ϩ ]i (n ϭ 12). For bar graphs, values are means Ϯ SE and are expressed relative to the control. **P Ͻ 0.01, ouabain treatment vs. control. thelial 22 Na ϩ flux (from apical to basolateral compartments) was determined. Ouabain treatment in the basolateral aspect significantly reduced transepithelial 22 Na ϩ flux, but no such effect was observed with apical exposure to ouabain (n ϭ 6; Fig. 1C Fig. 1D ). However, [Na ϩ ] i was significantly increased in response to high concentrations of ouabain (10 and 100 M, 30 min; data not shown). In LLC-PK1 monolayers, a low concentration of ouabain (100 nM) did not show any effect on transepithelial electrical resistance (45) . Consistently, low concentrations of ouabain have no discernable effects on tight junctions. Ouabain (100 nM for 1 h and up to 6 h) did not alter the expression ( Fig. 2A) or distribution of two tight junction proteins, occludin (Fig. 2, B and C) and claudin-1 (data not shown). In contrast, when LLC-PK1 monolayers were washed and incubated in Ca 2ϩ -free (with 1 mM EDTA) medium for 5 min before being immunostained for occludin, some broken tight junctions (defined as loss of tight contact of plasma membrane between two adjacent cells) could be demonstrated (Fig. 2D) .
The present data are consistent with the notion that ouabaininduced inhibition of NHE3 activity is due to the effect(s) of ouabain on basolateral Na ϩ -K ϩ -ATPase, which regulates both ion transporters to maintain intracellular Na ϩ homeostasis. Ouabain-induced NHE3 trafficking leads to the inhibition of NHE3 activity in LLC-PK1 cells. The observed acute change in NHE3 activity is most likely due to an alteration in NHE3 trafficking, because ouabain had no acute effect on NHE3 mRNA or total NHE3 protein expression up to 6 h (data not shown). To determine if ouabain could regulate NHE3 trafficking, we examined the distribution of NHE3 on the cell surface and in endosomes in response to ouabain.
After LLC-PK1 cells were treated with or without ouabain (100 nM, 1 h), whole cell lysates and membrane fractions were prepared and analyzed by Western blot. Tubulin served as the loading control. As shown in Fig. 3 , whereas chronic ouabain treatment (100 nM, 12 h) significantly reduced NHE3 expression in whole cell lysates (43), acute ouabain treatment (100 nM, 1 h) had no effect on NHE3 protein content in whole cell lysates (P Ͼ 0.05, n ϭ 6; Fig. 3A ), but it significantly reduced NHE3 content in membrane fractions (P Ͻ 0.01, n ϭ 6; Fig.  3B ). These observations were further confirmed by cell surface biotinylation experiments, which showed a significant decrease in cell surface NHE3 protein content in response to ouabain (100 nM, 1 h) added to the basolateral but not apical compartment (P Ͻ 0.01, n ϭ 4; Fig. 3C ). The observed decrease in NHE3 protein abundance in cell surface and membrane fractions, but not in whole cell lysates, suggests a redistribution of NHE3 in response to acute ouabain treatment. Under these conditions, the Na ϩ -K ϩ -ATPase ␣ 1 -subunit was also redistributed in the same pattern as seen in NHE3 (data not shown), consistent with our early observation (33) .
In addition to cell surface biotinylation, early and late endosomes were isolated to explore the redistribution status of NHE3. Early and late endosomes were isolated and identified with anti-EEA1, Rab5, and Rab7 antibodies. Ouabain (100 nM, 1 h) treatment significantly accumulated NHE3 protein in early endosomes (P Ͻ 0.01, n ϭ 9; Fig. 4) . Interestingly, the Na ϩ -K ϩ -ATPase ␣ 1 -subunit was also accumulated and coexisted with NHE3 in the same early endosome preparation in response to ouabain (P Ͻ 0.01, n ϭ 9; Fig. 4) . It is important to note that the accumulation of both proteins in the early endosomes appears to occur simultaneously, indicating coordinated regulation of both ion transporters by ouabain. Under these conditions, the Na ϩ -K ϩ -ATPase ␣ 1 -subunit was also accumulated in late endosomes, but no detectable NHE3 protein was observed in late endosomes (data not shown). ] i with the extracellular Na ϩ concentration was achieved using conventional "Na ϩ -clamping" methods in LLC-PK1 cells (24) . LLC-PK1 cells were pretreated with either 20 M monensin or 10 M monensin plus 5 M gramicidins for 30 min. Under both conditions, basal levels of NHE3 protein content in early endosomes were significantly increased, but ouabain (100 nM, 1 h) was still able to induce significant accumulation of NHE3 in early endosomes, as observed in normal control medium (Fig. 5) . Again, under the same Na ϩ -clamping conditions, ouabain also accumulated the Na ϩ -K ϩ -ATPase ␣ 1 -subunit in the same early endosome fraction (data not shown). These observations indicate that ouabain-induced trafficking of both NHE3 and Na
Activation of the basolateral Na
In LLC-PK1 cells, ouabain triggers signaling cascades involving the activation of c-Src kinase and phosphatidylinositol 3-kinase (PI3K), through the caveolar Na ϩ -K ϩ -ATPase/Src signaling complex. These cascades are critical in ouabaininduced endocytosis of Na ϩ -K ϩ -ATPase and transcriptional regulation of NHE3 (33, 34, 43) . In epithelial cells, lipid rafts and/or caveolae appear to play important roles in the trafficking of Na ϩ -K ϩ -ATPase and NHE3 (31, 34, 40) . To determine the role of caveolae and/or lipid rafts in the ouabain-induced trafficking of Na ϩ -K ϩ -ATPase and NHE3, caveolae and/or lipid rafts were disrupted and reestablished by cholesterol depletion (using M␤-CD) and repletion. Disruption of caveolae and/or lipid rafts by cholesterol depletion prevented the ouabain-induced accumulation of NHE3 in early endosomes, Fig. 4 . Ouabain accumulates NHE3 in early endosomes (EEs) but not in late endosomes (LEs). LLC-PK1 cells were treated with or without 100 nM ouabain for 1 h. EEs and LEs were isolated and identified as described in MATERIALS AND METHODS. The abundance of NHE3 and the Na ϩ -K ϩ -ATPase ␣1-subunit was detected by Western blot. No detectable NHE3 protein was observed in LEs. The Na ϩ -K ϩ -ATPase ␣1-subunit also accumulated in LEs (data not shown). Values are means Ϯ SE and are expressed relative to the control. **P Ͻ 0.01, ouabain treatment vs. control (n ϭ 9). Fig. 3 . Ouabain causes NHE3 redistribution in LLC-PK1 cells. A: representative Western blot of whole cell lysates before and after ouabain treatment (100 nM; bottom) and bar graph summary of the immunoblotting data (n ϭ 6; top). B: representative Western blot of membrane-associated NHE3 protein abundance before and after ouabain treatment (100 nM, 1 h; bottom) and bar graph summary of the immunoblotting data (n ϭ 6; top). C: representative Western blot of cell surface NHE3 as detected by cell surface protein biotinylation before and after ouabain treatment (100 nM, 1 h; bottom) and bar graph summary of the immunoblotting data (n ϭ 4; top). For bar graphs, values are means Ϯ SE and are expressed relative to the control. **P Ͻ 0.01, ouabain treatment vs. control. and cholesterol repletion restored the endosomal accumulation of NHE3 (Fig. 6) . Under the same conditions, the ouabaininduced accumulation of Na ϩ -K ϩ -ATPase was also prevented by cholesterol depletion and restored by repletion (data not shown and Ref. 34 ). Moreover, M␤-CD pretreatment also significantly prevented the effect of ouabain on NHE3-mediated H ϩ -driven 22 Na ϩ uptake (data not shown). To determine the effects of Src kinase and/or PI3K, LLC-PK1 cells were preincubated with a specific inhibitor of c-Src (1 M PP2) or PI3K (100 nM wortmannin) for 30 min and then treated with ouabain (100 nM, 1 h) in the presence of the inhibitor. Inhibition of c-Src or PI3K prevented not only the ouabaininduced downregulation of NHE3 activity (H ϩ -driven 22 Na ϩ uptake; Fig. 7A ) but also ouabain-induced NHE3 trafficking (determined by cell surface biotinylation; Fig. 7B ). PP2 or wortmannin alone did not show any effect. These observations indicate that ouabain-mediated NHE3 regulation is triggered by the ouabain-activated basolateral Na ϩ -K ϩ -ATPase/Src receptor complex.
Intracellular Ca 2ϩ is a potential "second messenger" in the ouabain-induced regulation of NHE3. Since ouabain inhibits transepithelial Na ϩ transport via a simultaneous regulation of the two transporters without changing [Na ϩ ] i , ouabain-activated basolateral signaling has to be "moved" from the basolateral aspect to the apical aspect. Ca 2ϩ signaling is involved in the control of Na ϩ handling in renal epithelial cells. Binding of ouabain to Na ϩ -K ϩ -ATPase has been shown to activate a [Ca 2ϩ ] i oscillatory signaling pathway in epithelial cells that is independent of changes in [Na ϩ ] i (1) . These findings led to the speculation that Ca 2ϩ signaling may be important in the ouabain-induced regulation of NHE3. Indeed, we observed that ouabain (100 nM) significantly increased [Ca 2ϩ ] i in LLC-PK1 cells in normal culture medium (Ca 2ϩ ϭ 1 mM), from 112.5 Ϯ 18.9 to 236.6 Ϯ 21.8 nM (n ϭ 12, P Ͻ 0.01), within 15 min. Pretreatment of LLC-PK1 cells with 10 M BAPTA-AM, a membrane-permeable Ca 2ϩ chelator, did not change basal [Ca 2ϩ ] i levels but attenuated ouabain-induced increases in [Ca 2ϩ ] i (131 Ϯ 16.9% with BAPTA-AM vs. 210 Ϯ 18.8% in control, n ϭ 9, P Ͻ 0.01). Consequently, it also attenuated ouabain-induced cell surface depletion and endosomal accumulation of NHE3 (Fig. 8) . This supports the notion that ouabain-activated Ca 2ϩ signaling may be a potential second messenger in the ouabain-induced regulation of NHE3.
DISCUSSION
In the renal proximal tubular cell, NHE3 is expressed in the apical membrane, playing a pivotal role in transepithelial Na ϩ reabsorption (2, 7, 47). Na ϩ -K ϩ -ATPase resides at the basolateral surface, providing the driving force for the active vectorial transport of Na ϩ from the tubular lumen to the vascular compartment. In addition to ion pumping, Na ϩ -K ϩ -ATPase also functions as a receptor and signal transducer (52) . Although Na ϩ -K ϩ -ATPase itself lacks tyrosine kinase activity, Na ϩ -K ϩ -ATPase and Src assemble into a functional receptor complex in the caveolae microdomain, which is capable of converting the extracellular ouabain signal to the activation of various signaling cascades (49, 50) . As part of this Na ϩ -K ϩ -ATPase signaling process, ouabain also induces clathrin-dependent endocytosis of Na ϩ -K ϩ -ATPase. This process requires caveolin-1 and the activation of c-Src kinase and PI3K (33, 34) . In renal epithelial cells, low concentrations of ouabain chronically reduce transepithelial Na ϩ transport without a concomitant rise in [Na ϩ ] i (43) . While our initial investigations of this phenomenon demonstrated that ouabain-activated Na ϩ -K ϩ -ATPase/Src signaling led to the transcriptional downregulation of NHE3, we could not exclude a possible acute effect on NHE3 activity that would be necessary to effect acute changes in transepithelial Na ϩ transport. The present study aimed to examine whether such acute effects could be demonstrated.
Our results suggest that acute exposure of LLC-PK1 cells to ouabain significantly inhibited transepithelial Na ϩ transport by simultaneously stimulating endocytosis of basolateral Na ϩ -K ϩ -ATPase and apical NHE3. This process is most likely triggered by the ouabain-activated Na ϩ -K ϩ -ATPase/Src receptor complex in the caveolae microdomain. Ouabain seems to have biphasic effects on NHE3 regulation; acutely it stimulates NHE3 trafficking and chronically it inhibits NHE3 expression. In both processes, ouabain-activated signaling plays a central role. First, ouabain treatment significantly reduced transepithelial Na ϩ transport without altering [Na ϩ ] i . These effects were only observed with ouabain treatment on the basolateral aspect, but not on the apical aspect, suggesting that the reduced apical Na ϩ entry is triggered at the basolateral membrane. Second, equilibrium of Na ϩ across the membrane by Na ϩ clamping did not prevent ouabain-induced early endosomal accumulation of NHE3 and Na ϩ -K ϩ -ATPase. Third, the ouabain effects on NHE3 activity and transepithelial Na ϩ transport were blocked by c-Src and PI3K inhibitors. Moreover, whereas caveolin-1 was required in the ouabain-induced transcriptional regulation of NHE3 and endocytosis of Na ϩ -K ϩ -ATPase, caveolae/lipid rafts were also involved in ouabain-induced NHE3 trafficking.
At this point, we cannot conclude if NHE3 activity is closely related to the cell surface NHE3 protein content, since NHE3 activity may also be regulated through its kinetic properties [V max , K Na ϩ, and K (H ϩ ) i ] (30, 40) . Even though we demonstrated a net decrease in cell surface NHE3 with a concomitant net accumulation of NHE3 in early endosomes, it is important to note that ouabain may also affect NHE3 exocytosis or recycling in this phenomenon. Since the isolated early endosomes may also contain recycling vesicles, accumulation of NHE3 in the early endosomal vesicles cannot be used as the only evidence for increased endocytosis. These issues remain to be resolved experimentally. We also noted that, in response to acute hypertension and parathyroid hormone treatment, NHE3 was redistributed to the base of microvilli but not to endosomes in the rat proximal tubule (53); however, cultured proximal tubule-derived cell lines lack microvilli and the intermicrovillar cleft structures found in the brush border of proximal tubules in situ (37) . This may account for the differences observed in cultured cells.
It (1, 39) . Fig. 7 . c-Src and phosphatidylinositol 3-kinase (PI3K) are involved in the ouabain-induced NHE3 endocytosis and inhibition of NHE3 activity. LLC-PK1 cells were pretreated with a c-Src specific inhibitor (PP2; 1 M, 30 min) or the PI3K-specific inhibitor wortmannin (Wort; 100 nM, 30 min) followed by ouabain treatment (100 nM, 1 h) in the continued presence of the respective inhibitor. A: H ϩ -driven 22 Na ϩ uptake in response to ouabain and inhibitors (n ϭ 4). B: abundance of cell surface NHE3 in response to ouabain and inhibitors (n ϭ 4). Values are means Ϯ SE and are expressed relative to the control. **P Ͻ 0.01, ouabain treatment vs. control. These data indicate that ouabain may function differently depending on the cell type and isoform. Interestingly, the binding of ouabain to Na ϩ -K ϩ -ATPase not only tethers PLC-␥ 1 and the inositol 1,4,5-trisphosphate receptor (IP 3 R) together to form a Ca 2ϩ -regulatory complex (54) but also stimulates the interaction of the NH 2 terminus of the endoplasmic reticulum-localized IP 3 R with the NH 2 terminus of the Na ϩ -K ϩ -ATPase ␣-subunit (55). These observations support the notion that ouabain-activated Na ϩ -K ϩ -ATPase signaling may also regulate NHE3 in the renal proximal tubule, since intracellular Ca 2ϩ has been shown to regulate NHE3 activity and trafficking (16, 29) .
Our observations also raise an interesting question: how does ouabain-activated basolateral Na ϩ -K ϩ -ATPase/Src signaling regulate apical NHE3? Except for the role in Ca 2ϩ signaling, it is reasonable to propose that ouabain-activated Na ϩ -K ϩ -ATPase signaling or endocytosed ouabain-Na ϩ -K ϩ -ATPase might serve as a "coupling point" in the regulation of transepithelial Na ϩ transport (32) . Receptor-mediated endocytosis has been shown not only to attenuate ligand-activated signaling but also to continue the signaling on the endocytic pathway, especially from endosomes (38, 48). Endocytic receptor tyrosine kinase (RTK) receptors could control the magnitude of the original signaling response (generated at the cell surface) or initiate distinct signaling cascades (qualitatively different from that generated at the cell surface) (51) . In polarized epithelial cells, distribution of RTK substrates could affect cellular responses (28) . The endosomal signaling appears to be dependent on both the receptor and cell type. In LLC-PK1 cells, ouabain not only induced compartmentalization of Na ϩ -K ϩ -ATPase, c-Src, EGF receptor, and ERK in early endosomes (33) but also bound to Na ϩ -K ϩ -ATPase along the endocytic route (12, 35) . Interestingly, caveolin-1 is also present in early or recycling endosomes. These facts make it possible that endosomal ouabain-Na ϩ -K ϩ -ATPase might be able to propagate its original signaling or to initiate distinct signaling cascades. This is supported by our findings that ouabain-induced NHE3 regulation is mediated by the activation of the receptor function of Na ϩ -K ϩ -ATPase. Furthermore, endocytosis is required for ouabain to remove basolateral Na ϩ -K ϩ -ATPase, which induces significant inhibition of the pumping activity. Moreover, blockade of Na ϩ -K ϩ -ATPase endocytosis appears to be sufficient to abolish ouabain-induced trafficking and transcriptional regulation of NHE3.
Although more work will be required to delineate the mechanism (like the role of NHE regulatory factor, NHE3 phosphorylation, and Ca 2ϩ signaling), the data presented here provides new evidence for the cardiotonic steroid-mediated regulation of transepithelial Na ϩ transport in the renal proximal tubule. This may represent an underlying mechanism of cardiotonic steroid-mediated renal adaptation to volume expansion and/or hypertension. In this process, it is logical to propose that ouabain-activated Na ϩ -K ϩ -ATPase signaling (from the cell surface and/or endosomes) may regulate Na ϩ handling via synchronous regulation of both basal and apical ion transporters, but the role of endocytic ouabain-Na ϩ -K ϩ -ATPase and Ca 2ϩ signaling in ouabain-induced NHE3 regulation remains unresolved.
